SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-23-081566
Filing Date
2023-10-30
Accepted
2023-10-30 16:50:25
Documents
13
Period of Report
2023-10-26
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea187417-8k_enzobio.htm   iXBRL 8-K 30904
2 AMENDED & RESTATED BYLAWS ea187417ex3-1_enzobio.htm EX-3.1 105640
  Complete submission text file 0001213900-23-081566.txt   337023

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE enz-20231026.xsd EX-101.SCH 3000
4 XBRL LABEL FILE enz-20231026_lab.xml EX-101.LAB 34240
5 XBRL PRESENTATION FILE enz-20231026_pre.xml EX-101.PRE 22350
7 EXTRACTED XBRL INSTANCE DOCUMENT ea187417-8k_enzobio_htm.xml XML 3302
Mailing Address ENZO BIOCHEM INC 60 EXECUTIVE BLVD FARMINGDALE NY 11735
Business Address 60 EXECUTIVE BLVD FARMINGDALE NY 11735 5167555500
ENZO BIOCHEM INC (Filer) CIK: 0000316253 (see all company filings)

IRS No.: 132866202 | State of Incorp.: NY | Fiscal Year End: 0731
Type: 8-K | Act: 34 | File No.: 001-09974 | Film No.: 231360995
SIC: 8071 Services-Medical Laboratories